Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

被引:439
作者
Rump, A
Morikawa, Y
Tanaka, M
Minami, S
Umesaki, N
Takeuchi, M
Miyajima, A
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, Tokyo 1130032, Japan
[2] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6410012, Japan
[3] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama 6410012, Japan
[4] Japan Sci & Technol Corp, CREST, Tokyo, Japan
关键词
D O I
10.1074/jbc.M312372200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesothelin is a glycosylphosphatidylinositol-linked cell surface molecule expressed in the mesothelial lining of the body cavities and in many tumor cells. Based on the finding that a soluble form of mesothelin specifically binds to ovarian carcinoma cell line OVCAR-3, we isolated cDNAs encoding a mesothelin-binding protein by expression cloning. The polypeptides encoded by the two cloned cDNA fragments matched to portions of CA125, an ovarian cancer antigen and a giant mucin-like glycoprotein present at the surface of tumor cells. By flow cytometric analysis and immunoprecipitation, we demonstrate that CA125 binds to mesothelin in a specific manner. Binding of CA125 to membrane-bound mesothelin mediates heterotypic cell adhesion as anti-mesothelin antibody blocks binding of OVCAR-3 cells expressing CA125 to an endothelial-like cell line expressing mesothelin. Finally, we show that CA125 and mesothelin are co-expressed in advanced grade ovarian adenocarcinoma. Taken together, our data indicate that mesothelin is a novel CA125-binding protein and that CA125 might contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to mesothelin.
引用
收藏
页码:9190 / 9198
页数:9
相关论文
共 64 条
[1]  
Argani P, 2001, CLIN CANCER RES, V7, P3862
[2]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[3]   Mesothelin is not required for normal mouse development or reproduction [J].
Bera, TK ;
Pastan, I .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (08) :2902-2906
[4]   Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values [J].
Bon, GG ;
Kenemans, P ;
Verstraeten, R ;
vanKamp, GJ ;
Hilgers, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) :107-114
[5]  
Boussioutas A, 2003, CANCER RES, V63, P2569
[6]  
Bresalier RS, 1996, CANCER RES, V56, P4354
[7]   MEDICAL PROGRESS - CANCER OF THE OVARY [J].
CANNISTRA, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) :1550-1559
[8]  
CANNISTRA SA, 1993, CANCER RES, V53, P3830
[9]   ISOLATION AND CHARACTERIZATION OF A MONOCLONAL-ANTIBODY, K1, REACTIVE WITH OVARIAN CANCERS AND NORMAL MESOTHELIUM [J].
CHANG, K ;
PASTAN, I ;
WILLINGHAM, MC .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (03) :373-381
[10]   Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers [J].
Chang, K ;
Pastan, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :136-140